05.06.19 Syndax Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Clinical and Business Update
04.29.19 Syndax to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 6, 2019
04.01.19 Syndax Pharmaceuticals Presents Updated Phase 2 Data from ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) at the American Association for Cancer Research 2019 Annual Meeting
